Adicet Bio, Inc. (ACET)
Nasdaq: ACET · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2017
Who runs Adicet Bio, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Schor Chen
President & CEO. First filing Jan 2018, latest Jun 23, 2026, 18 filings in all.
Officers reporting now
6
of 19 people with a filing in the last fifteen months
Directors reporting now
13
36 people on the record since 2018
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Klickstein Lloyd | Chief Medical Officer | May 2019 | Aug 7, 2026 | none |
| Schor Chen | President & CEO | Jan 2018 | Jun 23, 2026 | none |
| Aftab Blake | Chief Scientific Officer | Oct 2021 | Jun 23, 2026 | none |
| Harvey Brian Nicholas | Chief Financial Officer | Sep 2020 | Mar 27, 2026 | none |
| Healey Don | Chief Technology Officer | Oct 2020 | Mar 27, 2026 | none |
| Maltzman Julia D. | Chief Medical Officer | Jan 2025 | Mar 27, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Chodakewitz Jeffrey | director | Aug 2018 | Jun 23, 2026 | none |
| Dubin Steve | director | Sep 2020 | Jun 23, 2026 | none |
| Grissinger Michael | director | Nov 2018 | Jun 23, 2026 | none |
| Peng Katie | director | Jul 2023 | Jun 23, 2026 | none |
| Sinclair Andrew | director | Mar 2021 | Jun 23, 2026 | none |
| Orbimed Advisors Israel II Ltd | director | Sep 2020 | Apr 9, 2026 | 4 · $700,000 |
| Orbimed Advisors LLC | director | Jan 2018 | Apr 9, 2026 | none |
| Orbimed Capital Gp V LLC | director | Sep 2020 | Apr 9, 2026 | none |
| Orbimed Capital Gp Vi LLC | director | Jan 2018 | Apr 9, 2026 | none |
| Orbimed Genesis Gp LLC | director | Dec 2021 | Apr 9, 2026 | none |
| Orbimed Israel Biofund Gp Limited Partnership | director | Sep 2020 | Apr 9, 2026 | none |
| Orbimed Israel Gp II, L.P. | director | Sep 2020 | Apr 9, 2026 | none |
| Orbimed Israel Gp Ltd. | director | Sep 2020 | Apr 9, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Kolchinsky Peter | 10% owner | Feb 2026 | Apr 29, 2026 | none |
| Ra Capital Healthcare Fund LP | 10% owner | Feb 2026 | Apr 29, 2026 | none |
| Ra Capital Management, L.P. | 10% owner | Feb 2026 | Apr 29, 2026 | none |
| Shah Rajeev M. | 10% owner | Feb 2026 | Apr 29, 2026 | none |
Earlier names on the record18, newest filing first
Gordon Carl L · director · last filing Aug 2024Jakobovits Aya · director · last filing Aug 2024Kauffman Michael · director · last filing Aug 2024Galimi Francesco · officer · last filing Jun 2024Sanna Bastiano · director · last filing Aug 2023Chimovits Erez · director · last filing Jun 2023Abbot Stewart · officer · last filing Jun 2021Krehlik Carrie · officer · last filing Feb 2021Schindel Yair Chaim · director · last filing Sep 2020Fonteyne Paul R. · director · last filing Jun 2020Silverstein Jonathan · director · last filing Jun 2020Steinberg David Adam · director · last filing Jun 2020Sullivan Lynne Marie · director · last filing Jun 2020Puretech Health LLC · 10% owner · last filing Dec 2019Mccabe John J · officer · last filing Dec 2019Mannick Joan · officer · last filing Dec 2019Manning Meredith · officer · last filing Feb 2019Zohar Daphne · director · last filing Jan 2018
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.